Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

190.58
+4.192.25%
Post-market: 190.30-0.2800-0.15%19:41 EDT
Volume:6.20M
Turnover:1.18B
Market Cap:336.64B
PE:81.45
High:191.39
Open:186.92
Low:186.50
Close:186.39
Loading ...

AbbVie to Acquire Capstan Therapeutics, Expanding Commitment to Innovative Immunology Care

Reuters
·
30 Jun

Abbvie Inc - to Pay up to $2.1 Bln in Cash for Capstan

THOMSON REUTERS
·
30 Jun

Abbvie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology

THOMSON REUTERS
·
30 Jun

FDA Accepts Allergan Aesthetics' Premarket Approval Application for SKINVIVE by JUVÉDERM® to Improve Neck Appearance

Reuters
·
30 Jun

U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for Skinvive by JuvÉDerm® for the Improvement of Neck Appearance

THOMSON REUTERS
·
30 Jun

AbbVie Inc. to Announce Second-Quarter 2025 Financial Results

Reuters
·
30 Jun

AbbVie Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
28 Jun

AbbVie’s Promising Phase 3 Study on Lutikizumab for Hidradenitis Suppurativa

TIPRANKS
·
27 Jun

AbbVie’s Study on Mitigating Ocular Toxicity in Ovarian Cancer Treatment

TIPRANKS
·
27 Jun

AbbVie Advances Real-world Study on OZURDEX for Diabetic Macular Edema in China

TIPRANKS
·
27 Jun

AbbVie’s Upadacitinib Study: A Potential Game-Changer for SLE Treatment

TIPRANKS
·
27 Jun

Incyte Corporation Appoints Bill Meury as New CEO, Hervé Hoppenot Retires After 11 Years of Leadership

Reuters
·
26 Jun

AbbVie’s Phase 3 AML Study: Venetoclax and Azacitidine in Focus

TIPRANKS
·
26 Jun

AbbVie Keeps Quarterly Dividend at $1.64 per Share; Payable Aug. 15 to Holders of Record as of July 15

MT Newswires Live
·
20 Jun

AbbVie Inc. Declares Quarterly Dividend of $1.64 per Share

Reuters
·
20 Jun

Abbvie Inc - Declares Quarterly Cash Dividend of $1.64 per Share

THOMSON REUTERS
·
20 Jun

AbbVie (ABBV) Gets a Hold from Citi

TIPRANKS
·
20 Jun

Bernstein Sticks to Its Hold Rating for AbbVie (ABBV)

TIPRANKS
·
20 Jun

Wells Fargo Remains a Buy on AbbVie (ABBV)

TIPRANKS
·
19 Jun

Simcere Zaiming Begins Phase 1 Trial of Trispecific Antibody SIM0500 for Multiple Myeloma in the US

Reuters
·
19 Jun